1. Bingaman WE, Frank JI. Malignant cerebral edema and intracranial hypertension. Neurol Clin 1995;13:479–509.
2. Prough DS, Johnson JC, Poole GV Jr, Stullken EH, Johnston WE Jr, Royster R. Effects on intracranial pressure of resuscitation from hemorrhagic shock with hypertonic saline versus lactated Ringer’s solution. Crit Care Med 1985;13:407–411.
4. Suarez JI, Qureshi AI, Bhardwaj A, et al. Treatment of refractory intracranial hypertension with 23.4% saline. Crit Care Med 1998;26:1118–1122.
5. Chugh AJ, Maynard M, Sunshine K, et al. Role of continuous hypertonic saline in acute ischemic infarcts: a systematic literature review. J Neurocrit Care 2021;14:1–7.
7. Shi J, Tan L, Ye J, Hu L. Hypertonic saline and mannitol in patients with traumatic brain injury: a systematic and meta-analysis. Medicine (Baltimore) 2020;99:e21655.
8. Rackimuthu S, Ishwara PR, Suresh S. Complications associated with osmotic therapy in acute stroke patients: a prospective longitudinal observational study. J Clin Diagn Res 2020;14:OC05–OC08.
9. Aviram A, Pfau A, Czaczkes JW, Ullmann TD. Hyperosmolality with hyponatremia, caused by inappropriate administration of mannitol. Am J Med 1967;42:648–650.
10. Dorman HR, Sondheimer JH, Cadnapaphornchai P. Mannitol-induced acute renal failure. Medicine (Baltimore) 1990;69:153–159.
11. Oster JR, Singer I. Hyponatremia, hyposmolality, and hypotonicity: tables and fables. Arch Intern Med 1999;159:333–336.
13. Fanous AA, Tick RC, Gu EY, Fenstermaker RA. Life-threatening mannitol-induced hyperkalemia in neurosurgical patients. World Neurosurg 2016;91:672.
14. Rasouli M. Basic concepts and practical equations on osmolality: biochemical approach. Clin Biochem 2016;49:936–941.
15. Better OS, Rubinstein I, Winaver JM, Knochel JP. Mannitol therapy revisited (1940-1997). Kidney Int 1997;52:886–894.
16. Dickenmann M, Oettl T, Mihatsch MJ. Osmotic nephrosis: acute kidney injury with accumulation of proximal tubular lysosomes due to administration of exogenous solutes. Am J Kidney Dis 2008;51:491–503.
17. Gondim Fde A, Aiyagari V, Shackleford A, Diringer MN. Osmolality not predictive of mannitol-induced acute renal insufficiency. J Neurosurg 2005;103:444–447.
18. Lin SY, Tang SC, Tsai LK, et al. Incidence and risk factors for acute kidney injury following mannitol infusion in patients with acute stroke: a retrospective cohort study. Medicine (Baltimore) 2015;94:e2032.
19. Pirzada NA, Ali II. Central pontine myelinolysis. Mayo Clin Proc 2001;76:559–562.
20. Duran R, Aladağ N, Vatansever U, Temízöz O, Gençhallaç H, Acunaş B. Cranial MR venography findings of severe hypernatremic dehydration in association with cerebral venous thrombosis in the neonatal period. Pediatr Hematol Oncol 2007;24:387–391.
21. Perez CA, Figueroa SA. Complication rates of 3% hypertonic saline infusion through peripheral intravenous access. J Neurosci Nurs 2017;49:191–195.
22. Riha HM, Erdman MJ, Vandigo JE, et al. Impact of moderate hyperchloremia on clinical outcomes in intracerebral hemorrhage patients treated with continuous infusion hypertonic saline: a pilot study. Crit Care Med 2017;45:e947–e953.
23. Traficante D, Galaktionova D, Marseille U, Hochman S, Zuberi J, Madlinger R. Comparison of 3% vs. 23.4% hypertonic saline in traumatic brain injury. J Curr Surg 2019;9:39–44.
24. Reed RL 2nd, Johnston TD, Chen Y, Fischer RP. Hypertonic saline alters plasma clotting times and platelet aggregation. J Trauma 1991;31:8–14.
26. Ragland J, Lee K. Critical care management and monitoring of intracranial pressure. J Neurocrit Care 2016;9:105–112.